Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Petra Kaniokova Vesela

Petra Kaniokova Vesela

Charles University, Czech Republic

Title: Serum leptin level as a marker of bone metabolism in pre-term babies

Biography

Biography: Petra Kaniokova Vesela

Abstract

Many hormonal changes can be observed in hormonal enviroment after birth. These changes lead to an increase in endosteal bone resorption. The adapation process in preterm infants is different, and depends on the maturity. Thus, two mainstream hypotheses for the role of leptin on bone have emerged: (i) direct regulation through increased osteoblast proliferation and differentiation and (ii) indirect suppression of bone formation through a hypothalamic relay. At the present time, it remains unclear whether these effects are relevant in only extreme circumstances (i.e. models with complete deficiency) or play an important homeostatic role in the regulation of peak bone acquisition and skeletal remodeling. The leptin acts primarily through peripheral pathways and increases osteoblast numbers and activity. Leptin plays an important role in the regulation of bone metabolism. It directly influences osteoblast proliferation and differentiation. Indirectly, leptin affects bone formation through a hypothalamic relay. The leptin level in the cord blood of preterm newborns is significantly lower than the leptin level in the cord blood of term delivered newborns. However, leptin levels in the cord blood in newborns delivered between 32+0 and 36+6 weeks of gestation do not significantly influence the lumbar spine BMD at 2 years of age.